Cinctive Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,576
| Closed | -$573K | – | 392 |
|
|
2024
Q4 | $573K | Buy |
+10,576
| New | +$573K | 0.03% | 297 |
|
|
2024
Q3 | – | Sell |
-10,181
| Closed | -$448K | – | 442 |
|
|
2024
Q2 | $448K | Buy |
10,181
+5,968
| +142% | +$262K | 0.02% | 334 |
|
|
2024
Q1 | $212K | Buy |
+4,213
| New | +$212K | 0.01% | 355 |
|
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$108K | – | 464 |
|
|
2020
Q4 | $108K | Buy |
+10,000
| New | +$108K | 0.01% | 308 |
|